A Phase III Clinical Trial to Study the Safety, Tolerability, and Immunogenicity of ZOSTAVAX (R) in Healthy Adults in Taiwan

Trial Profile

A Phase III Clinical Trial to Study the Safety, Tolerability, and Immunogenicity of ZOSTAVAX (R) in Healthy Adults in Taiwan

Completed
Phase of Trial: Phase III

Latest Information Update: 11 Feb 2015

At a glance

  • Drugs Varicella zoster virus vaccine live (Primary)
  • Indications Herpes zoster
  • Focus Pharmacodynamics
  • Sponsors Merck & Co
  • Most Recent Events

    • 20 Oct 2008 Actual end date (May 2007) added as reported by ClinicalTrials.gov.
    • 20 Oct 2008 Actual study start date changed from (Mar 2007) to (Feb 2007) reported by ClinicalTrials.gov.
    • 20 Oct 2008 Trial identifier changed from (V211-019) to (MKV211-019) as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top